1. Home
  2. CXE vs LNSR Comparison

CXE vs LNSR Comparison

Compare CXE & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS High Income Municipal Trust

CXE

MFS High Income Municipal Trust

HOLD

Current Price

$3.74

Market Cap

118.1M

Sector

Finance

ML Signal

HOLD

Logo LENSAR Inc.

LNSR

LENSAR Inc.

HOLD

Current Price

$12.56

Market Cap

136.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXE
LNSR
Founded
1989
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Electronics
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.1M
136.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CXE
LNSR
Price
$3.74
$12.56
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
62.9K
30.5K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
4.36%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
N/A
$59,141,000.00
Revenue This Year
N/A
$19.55
Revenue Next Year
N/A
$35.89
P/E Ratio
$51.00
N/A
Revenue Growth
N/A
21.02
52 Week Low
$2.95
$8.25
52 Week High
$3.67
$17.31

Technical Indicators

Market Signals
Indicator
CXE
LNSR
Relative Strength Index (RSI) 50.99 68.69
Support Level $3.63 $11.86
Resistance Level $3.78 $12.09
Average True Range (ATR) 0.03 0.31
MACD -0.00 0.06
Stochastic Oscillator 48.00 99.61

Price Performance

Historical Comparison
CXE
LNSR

About CXE MFS High Income Municipal Trust

Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.

Share on Social Networks: